Low protein

About: Low protein is a research topic. Over the lifetime, 8139 publications have been published within this topic receiving 213225 citations.

Rivastigmine, a New-Generation Cholinesterase Inhibitor for the Treatment of Alzheimer's Disease

Abstract: Rivastigmine is a cholinesterase inhibitor (ChEI) with a structural formula different from that of currently available ChEIs. Tacrine and donepezil are classified as short-acting or reversible agents since binding to acetylcholinesterase enzyme (AChE) is hydrolyzed within minutes. Rivastigmine is classified as an intermediate-acting or pseudo-irreversible agent due to its long inhibition on AChE of up to 10 hours. Preclinical biochemical studies indicated that rivastigmine has central nervous system selectivity over peripheral inhibition. It ameliorated memory impairment in rats with forebrain lesions. The drug is rapidly absorbed orally, with a bioavailability of 0.355 and low protein binding (40%). Its elimination half-life is less than 2 hours, and it is converted to an inactive metabolite at the site of action, bypassing hepatic metabolic pathways. Its disposition essentially is unaltered in patients with renal or hepatic impairment. It also has dose-dependent effects on AChE inhibition. In the two large multicenter clinical trials (total 1324 patients) that used a forced-dosage titration scheme, rivastigmine 6-12 mg/day was superior to placebo on three cognitive and functioning scales (p<0.001). Gastrointestinal symptoms are the most frequently reported adverse events. They occurred mostly during the dosage titration phase and decreased during the maintenance phase. Rivastigmine offers clinicians another therapeutic agent to treat Alzheimer's disease.

Controlled low protein diets in chronic renal insufficiency: meta-analysis.

Abstract: OBJECTIVE--To determine whether low protein diets retard the development of end stage renal disease. DESIGN--Meta-analysis of 46 trials since 1975, from which six randomised controlled trials were selected. SETTING--Five trials in Europe and one in Australia between 1982 and 1991. SUBJECTS--890 patients with mild to severe chronic renal failure who were followed up for at least one year. 450 patients received a low protein diet and 440 a control diet. INTERVENTION--Difference in protein intake between control and treated groups of at least 0.2 g protein/kg/day. MAIN OUTCOME MEASURE--Number of renal deaths (the necessity to start dialysis or death of patient during study). RESULTS--156 renal deaths were recorded, 61 in the low protein diet group and 95 in the control group, leading to an odds ratio of low protein to control of 0.54 with a 95% confidence interval of 0.37 to 0.79. CONCLUSIONS--This result, obtained on a large population of patients suffering from chronic renal insufficiency, strongly supports the effectiveness of low protein diets in delaying the onset of end stage renal disease.

Hypothalamic Nuclei Are Malformed in Weanling Offspring of Low Protein Malnourished Rat Dams

Abstract: Maternal low protein malnutrition during gestation and lactation (LP) is an animal model frequently used for the investigation of long-term deleterious consequences of perinatal growth retardation. Both perinatal malnutrition and growth retardation at birth are risk factors for diabetic and cardiovascular disturbances in later life. The pathophysiologic mechanisms responsible are unknown. Hypothalamic nuclei are decisively involved in the central nervous regulation of food intake, body weight and metabolism. We investigated effects of a low protein diet (8% protein; control diet, 17% protein) during gestation and lactation in rat dams on the organization of hypothalamic regulators of body weight and metabolism in the offspring at weaning (d 20 of life). LP offspring had significantly lower body weight than control offspring (CO; P: < 0.001), associated with hypoglycemia and hypoinsulinemia (P: < 0. 005) on d 20 of life. This was accompanied by a greater relative volume of the ventromedial hypothalamic nucleus (P: < 0.01) and a greater numerical density of Nissl-stained neurons in this nucleus (P: < 0.01) as well as in the paraventricular hypothalamic nucleus (PVN; P: < 0.001). In contrast, no significant differences in neuronal densities were observed generally in the lateral hypothalamic area, arcuate hypothalamic nucleus (ARC), and dorsomedial hypothalamic nucleus between LP offspring and CO offspring. On the other hand, LP offspring displayed fewer neurons immunopositive for neuropeptide Y in the ARC (P: < 0.05), whereas in the PVN, lower neuronal densities of neurons immunopositive for galanin were found in LP offspring compared with CO offspring (P: < 0.001). On the contrary, in the PVN, no significant group difference in the numerical density of cholecystokinin-8S-positive neurons was present. A long-term effect of these specific hypothalamic alterations on body weight and metabolism in LP offspring during later life is suggested.

Protein Digestibility of Cereal Products

Abstract: Protein digestibility is currently a hot research topic and is of big interest to the food industry. Different scoring methods have been developed to describe protein quality. Cereal protein scores are typically low due to a suboptimal amino acid profile and low protein digestibility. Protein digestibility is a result of both external and internal factors. Examples of external factors are physical inaccessibility due to entrapment in e.g., intact cell structures and the presence of antinutritional factors. The main internal factors are the amino acid sequence of the proteins and protein folding and crosslinking. Processing of food is generally designed to increase the overall digestibility through affecting these external and internal factors. However, with proteins, processing may eventually also lead to a decrease in digestibility. In this review, protein digestion and digestibility are discussed with emphasis on the proteins of (pseudo)cereals.

Cassava wastes: treatment options and value addition alternatives.

Abstract: Value addition of cassava and cassava wastes is necessitated by rapid post-harvest spoilage, deterioration, low protein content and environmental pollution caused by the effluent and the other associated wastes that poses aesthetic nuisance. Biogas plants of all sizes and varying levels of technical sophistication not only recover the energy contained in cassava wastes but also eliminate most of the animal and human health problems associated with contamination. Studies have shown the technical feasibility and nutritional desirability of converting carbohydrates and their residues into products containing a large amount of protein by means of microorganisms. Wastes transformation offers the possibility of creating marketable value-added products. There exists a great potential in the use of microorganisms such as fungi for the production of high quality feedstuffs from the abundantly available agro-industrial wastes, particularly carbohydrate residues. Cassava wastes can be processed and converted into value-added components such as methane (biogas), pig meat, ethanol, surfactant and fertilizer etc. Attention is now focused on the by-products of the anaerobic decomposition of the waste that takes place in a biodigester, which are the liquid fraction called biol and the solid fraction or biosol, which are excellent fertilizers for a variety of crops. The present review addresses the progress that has been made in each of these aspects with emphasis on the advantages of biol and biosol fertilizers. Key words: Carbohydrate residue, waste transformation, biofertilizers.